The Eastman Chemical Company (EMN) has been in the spotlight lately due to various reasons. Investment firms like DAVENPORT and Co and Invenomic Capital Management have increased their positions in EMN, while others like JP Morgan Chase, Franklin Resources, and Citigroup have lowered theirs. Amidst these adjusting positions, the company has had an upward stock price movement, coupled with a slightly raised dividend. Analysts are bullish on Eastman's expanded self-help plan that focuses on cost cuts and cash commitments through 2026.
However, Eastman's last quarter earnings and sales lagged due to weak demand, leading to a lowering of its stock by several key market players. The company has seen a downward trend in its Q3 2025 earnings due to strategic cost reductions. Speculation grows over whether Eastman is rewriting its investment story through its cost cutting measures and ETP execution. Despite a Miss in Q3 earnings and sales, and the stock price dropping, Eastman's sustainability initiatives and focus on cash-first policies have generated positive perceptions. To overcome tariff impact, EMN's outlook was cut to negative by S&P.
Eastman Chemical Company EMN News Analytics from Thu, 24 Apr 2025 07:00:00 GMT to Wed, 25 Mar 2026 08:47:47 GMT - Rating 3 - Innovation -2 - Information 7 - Rumor -6
